Hikma, Civica to reduce generic drug shortages in the US
World | News | 0 Comment | 22 Jul, 2019
Hikma Pharmaceuticals PLC,the multinational generic pharmaceutical company and Civica Rx (Civica, Inc.) have announced a...Read more
US researchers design 3D printed indigestible pill
World | News | 0 Comment | 29 Jul, 2019
A research team led by Tufts University engineers in the US has developed a 3D printed ingestible pill that samples bact...Read more
PerkinElmer to expand At Home health services
World | News | 0 Comment | 26 Jul, 2019
PerkinElmer, Inc. and EverlyWell, Inc. have announced a new collaboration designed to accelerate innovati...Read more
Cipla USA acquires worldwide rights for UTI drug
World | News | 0 Comment | 25 Jul, 2019
Cipla USA Inc., a wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited, announce...Read more
Olon expands microbial GMP capabilities in Capua site
World | News | 0 Comment | 24 Jul, 2019
Olon S.p.A., a world leading Active Pharmaceutical Ingredients (API) contract development and manufacturing organization...Read more
Sanofi signs deal for exclusive US OTC rights to Tamiflu
World | News | 0 Comment | 24 Jul, 2019
Sanofi signed an agreement with Roche for the exclusive over-the-counter (OTC) rights to Tamiflu® for the preve...Read more
Medtronic partners with Viz.ai
World | News | 0 Comment | 24 Jul, 2019
Medtronic plc, a global leader in medical technology, and Viz.ai, the emerging leader in applied artificial intelligence...Read more
NIH publishes largest genomic study on type 2 diabetes in sub-Saharan African populations
World | News | 0 Comment | 23 Jul, 2019
National Institute of Health researchers have reported the largest genomic study of type 2 diabetes (T2D) in sub-Saharan...Read more
Yellow Wood Partners to acquire Dr. Scholl’s from Bayer
World | News | 0 Comment | 23 Jul, 2019
Yellow Wood Partners has entered into a definitive agreement to buy the Dr. Scholl’s™ business from Bayer fo...Read more
WHO recommends dolutegravir as preferred HIV treatment option
World | News | 0 Comment | 23 Jul, 2019
Based on new evidence assessing benefits and risks, the WHO recommends the use of the HIV drug dolutegravir (DTG) as the...Read more
Medicxi closes €400m Fund (Medicxi III)
World | News | 0 Comment | 22 Jul, 2019
Leading European life sciences investment firm Medicxi has announced the closing of Medicxi III, a new €400 million...Read more
Merck and Broad Institute announce CRISPR license framework
World | News | 0 Comment | 19 Jul, 2019
Merck, a leading science and technology company, and the Broad Institute of MIT and Harvard (Boston,...Read more
TraceLink partners with Excellis Health Solutions
World | News | 0 Comment | 18 Jul, 2019
TraceLink Inc., the world's largest integrated digital supply network, providing real-time information sharing for bette...Read more
Chad Mirkin wins Kabiller Prize in nanoscience and nanomedicine
World | News | 0 Comment | 16 Jul, 2019
Exicure, a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA) constructs...Read more
Recursion Pharmaceuticals secures $121M in Series C funding
World | News | 0 Comment | 16 Jul, 2019
Recursion, a next-gen biopharma company combining automated, experimental biology with artificial intelligence to discov...Read more
Illumina expands Genomics Accelerator to Cambridge, UK
World | News | 0 Comment | 16 Jul, 2019
Illumina has announced the global expansion of Illumina Accelerator to Cambridge, United Kingdom. Founded in the Sa...Read more
Gilead Sciences, Renown Institute for Health Innovation collaborate for NASH
World | News | 0 Comment | 16 Jul, 2019
Gilead Sciences and the Renown Institute for Health Innovation (IHI) have announced a strategic collaboration to co...Read more
J&J announces PPP for Investigational Prophylactic HIV Vaccine
World | News | 0 Comment | 16 Jul, 2019
Johnson & Johnson has announced that Janssen Vaccines & Prevention B.V., one of its Janssen Pharmaceutical Compa...Read more